Supply of Promethazine Hydrochloride Tablets (Pharmaceutical Product)

The contract mandates the procurement and delivery of 5,000 bottles of Promethazine Hydrochloride Tablets, a pharmaceutical product subject to strict federal regulatory standards ensuring safety, efficacy, and quality compliance. The supplier must adhere to all applicable federal pharmaceutical guidelines and fully comply with the Defense Logistics Agency’s specialized military packaging requirements, which include labeling, containment, and documentation protocols designed for secure transport and storage within defense supply chains. The product is intended for use in military medical facilities and must meet all performance and stability criteria outlined for pharmaceuticals deployed under operational conditions. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325412 indicating classification within pharmaceutical and medicine manufacturing. The contract was posted on August 5, 2026, and is formally linked to the award documentation under contract number SPE2DX25D9900 and delivery order SPE2DP26F8767. Although no specific place of performance or point of contact is listed, delivery is expected to support DLA’s centralized distribution network, and all packaging must be configured to meet the unique demands of military logistics including environmental resilience, traceability, and readiness for rapid deployment. Compliance with these standards is mandatory for contract fulfillment and acceptance.